Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News InspireMD Inc NSPR

Healthcare Medical Instruments & Supplies
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet... see more

Recent & Breaking News (NDAQ:NSPR)

Long-term Clinical Data on InspireMD's CGuard Embolic Prevention System to be Presented at Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium

Marketwired October 27, 2016

InspireMD Announces Appointment of Medical Device Industry Veteran Agustin Gago as Chief Commercial Officer

Marketwired October 26, 2016

12 Biggest Mid-Day Losers For Monday

Benzinga.com  October 17, 2016

InspireMD Announces Independent Study Published in the Journal of Endovascular Therapy That Continues to Support the Clinical Benefit and Utility of the CGuard Embolic Prevention System

Marketwired October 17, 2016

InspireMD to Present at the Dawson James Securities 2nd Annual Growth Stock Conference on October 20

Marketwired October 13, 2016

InspireMD Announces Adjustments to Shares Receivable Upon Warrant Exercise and Exercise Price per Share

Marketwired October 6, 2016

InspireMD Announces 1-for-25 Reverse Stock Split

Marketwired September 28, 2016

InspireMD Appoints Thomas Kester to Board of Directors

Marketwired September 7, 2016

InspireMD Reports Financial Results for the Second Quarter Ended June 30, 2016

Marketwired August 9, 2016

InspireMD to Report Second Quarter Financial Results on Tuesday, August 9, 2016

Marketwired August 2, 2016

UPDATE - InspireMD Announces Listing of Warrants on the NYSE MKT

Marketwired August 1, 2016

InspireMD Regains Compliance With NYSE MKT Listing Standards

Marketwired July 21, 2016

InspireMD Announces Closing of Public Offering of Approximately $14.6 Million

Marketwired July 7, 2016

9 Biggest Mid-Day Losers For Friday

Benzinga.com  July 1, 2016

InspireMD Announces Amendment to Loan & Security Agreement With Hercules Capital

Marketwired June 14, 2016

InspireMD Names Dr. James Barry as President and CEO

Marketwired June 7, 2016

UPDATE: InspireMD Receives Audit Opinion With Going Concern Explanation

Marketwired March 31, 2016

InspireMD Receives Audit Opinion With Going Concern Explanation

Marketwired March 31, 2016

Dawson James Securities Announces Closing of $1.75 Million Offerings with InspireMD, Inc.

Accesswire March 31, 2016

InspireMD Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015

Marketwired March 28, 2016